Time to effect of fixed-dose subcutaneous (SC) C1 inhibitor liquid for prophylactic treatment of hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE): results from the phase 3 SAHARA study-MedSci.cn

Time to effect of fixed-dose subcutaneous (SC) C1 inhibitor liquid for prophylactic treatment of hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE): results from the phase 3 SAHARA study

Riedl, MA; Johnston, DT; Tang, T; Vardi, M; Bernstein, JA

ALLERGY, 2018; 73 (): 288

科室
- - 订阅+
  - 更多科室
工具
服务